EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

Risk Factors of FEV 1 /FVC Decline in COPD Patients

Na Young Kim iD, Deog Kyeom Kim iD, Shinhee Park iD, Yong Il Hwang iD, Hyewon Seo iD, Dongil Park iD, Seoung Ju Park iD, Jin Hwa Lee iD, Kwang Ha Yoo iD, Hyun Woo Lee iD

Journal of Korean Medical Science · 2025

DOI: 10.3346/jkms.2025.40.e32 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Korean Medical Science, 2025. Verfasst von Na Young Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Factors influencing the decline in forced expiratory volume in one second (FEV₁)/forced vital capacity (FVC) for chronic obstructive pulmonary disease (COPD) progression remain uncertain. We aimed to identify risk factors associated with rapid FEV₁/FVC decline in patients with COPD. METHODS: This multi-center observational study was conducted from January 2012 to December 2022. Eligible patients were monitored with symptoms, spirometric tests, and treatment patterns over 3 years. Rapid FEV₁/FVC decliners were defined as the quartile of patients exhibiting the highest annualized percentage decline in FEV₁/FVC. RESULTS: Among 1,725 patients, 435 exhibited rapid FEV₁/FVC decline, with an annual change of -2.5%p (interquartile range, -3.5 to -2.0). Rapid FEV₁/FVC decliners exhibited lower body mass index (BMI), higher smoking rates, elevated post-bronchodilator (BD) FEV₁, higher post-BD FEV₁/FVC, and a lower prevalence of Staging of Airflow Obstruction by Ratio (STAR) stage IV. Rapid FEV₁/FVC decline was not linked to the annual exacerbation rate, but there was an association with symptom deterioration and FEV₁ decline. In multivariable analyses, low BMI, current smoking, increased modified Medical Research Council dyspnoea score, low post-BD FEV₁, low STAR stage, high forced mid-expiratory flow (FEF25-75%), accelerated FEV₁ decline, and not initiating dual BD therapy were identified as independent risk factors for rapid FEV₁/FVC decline. CONCLUSION: We identified the risk factors for rapid FEV₁/FVC decline, including BMI, smoking, symptoms deterioration, FEV₁ decline, and adherence to standard inhaler treatment. Our findings underscore the potential benefits of maintaining consistent use of long-acting beta-agonist/long-acting muscarinic antagonist even in the presence of worsening symptoms, in attenuating FEV₁/FVC decline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveHumansMaleFemaleForced Expiratory VolumeRisk FactorsMiddle AgedAgedVital CapacityBody Mass IndexSmokingDisease ProgressionBronchodilator AgentsSpirometrySeverity of Illness Index

Stichwörter der Autor:innen

Chronic Obstructive Pulmonary DiseaseCohort StudiesForced Expiratory VolumeForced Vital CapacityRespiratory Function TestsRisk Factors

Substanzen

Bronchodilator Agents

Autor:innen und Institutionen

  • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Ko…
  • Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
  • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
  • Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.
  • Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea.

ORCID-Profile: Na Young Kim, Deog Kyeom Kim, Shinhee Park, Yong Il Hwang, Hyewon Seo, Dongil Park, Seoung Ju Park, Jin Hwa Lee, Kwang Ha Yoo, Hyun Woo Lee

Förderung

  • Korea National Institute of Health

Zitieren

APA

Kim, N. Y., Kim, D. K., Park, S., Hwang, Y. I., Seo, H., Park, D., Park, S. J., Lee, J. H., Yoo, K. H., & Lee, H. W. (2025). Risk Factors of FEV 1 /FVC Decline in COPD Patients. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2025.40.e32

Vancouver

Kim NY, Kim DK, Park S, Hwang YI, Seo H, Park D, et al. Risk Factors of FEV 1 /FVC Decline in COPD Patients. Journal of Korean Medical Science. 2025. doi:10.3346/jkms.2025.40.e32

BibTeX
@article{Kim2025,
  author = {Kim, Na Young and Kim, Deog Kyeom and Park, Shinhee and Hwang, Yong Il and Seo, Hyewon and Park, Dongil and Park, Seoung Ju and Lee, Jin Hwa and Yoo, Kwang Ha and Lee, Hyun Woo},
  title = {Risk Factors of FEV 1 /FVC Decline in COPD Patients},
  journal = {Journal of Korean Medical Science},
  year = {2025},
  doi = {10.3346/jkms.2025.40.e32}
}
Kostenlos starten →